Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Liabilities and Shareholders Equity (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Liabilities and Shareholders Equity for 11 consecutive years, with $5.0 million as the latest value for Q3 2022.

  • Quarterly Liabilities and Shareholders Equity rose 49.68% to $5.0 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2022, up 27.54% year-over-year, with the annual reading at $3.0 million for FY2021, N/A changed from the prior year.
  • Liabilities and Shareholders Equity hit $5.0 million in Q3 2022 for Kraig Biocraft Laboratories, down from $5.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $5.4 million in Q2 2022 to a low of $71383.0 in Q4 2018.
  • Historically, Liabilities and Shareholders Equity has averaged $2.2 million across 4 years, with a median of $1.3 million in 2019.
  • Biggest five-year swings in Liabilities and Shareholders Equity: crashed 47.31% in 2018 and later skyrocketed 596.95% in 2019.
  • Year by year, Liabilities and Shareholders Equity stood at $71383.0 in 2018, then surged by 1158.86% to $898609.0 in 2019, then surged by 236.29% to $3.0 million in 2021, then soared by 65.15% to $5.0 million in 2022.
  • Business Quant data shows Liabilities and Shareholders Equity for KBLB at $5.0 million in Q3 2022, $5.4 million in Q2 2022, and $4.6 million in Q1 2022.